IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries
Sun, Guo-ping; Sun, Yan; Xu, Rui-hua; Xu, Jian-Ming; Li, Jin; Wang, Jin-Wan; Qin, Shukui; Feng, Ji Feng; Ba, Yi; Shen, Lin; Bai, Yu-Xian; Sun, Yihong; Pan, Hongming; Cheng, Ying; Yu, Shiying; Zhong, Haijun; Bai, Li; Luo, Rongcheng; Kobayashi, Mikiro; Ohtsu, Atsushi
刊名JOURNAL OF CLINICAL ONCOLOGY
2013-05-20
suppl.S期:15
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000335419601482
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56149
专题北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位1.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
2.Beijing 301 PLA Hosp, Beijing, Peoples R China
3.Guangzhou Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
4.GSK Japan Tokyo Head Off, Tokyo, Japan
5.Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
6.Jilin Prov Canc Hosp, Changchun, Peoples R China
7.Tongji Hosp, Ctr Oncol, Wuhan, Peoples R China
8.An Hui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
9.Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
10.Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
11.Acad Mil Med Sci, Hosp 307, Ctr Canc, Beijing, Peoples R China
12.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
13.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
14.Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China
15.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
16.Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
17.Peking Univ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp, Beijing 100871, Peoples R China
18.Harbin Med Univ, Tumor Hosp, Harbin, Peoples R China
19.Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
20.Shao Yifu Hosp, Hangzhou, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Sun, Guo-ping,Sun, Yan,Xu, Rui-hua,et al. The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
APA Sun, Guo-ping.,Sun, Yan.,Xu, Rui-hua.,Xu, Jian-Ming.,Li, Jin.,...&Ohtsu, Atsushi.(2013).The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries.JOURNAL OF CLINICAL ONCOLOGY,suppl.S(15).
MLA Sun, Guo-ping,et al."The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries".JOURNAL OF CLINICAL ONCOLOGY suppl.S.15(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Sun, Guo-ping]的文章
[Sun, Yan]的文章
[Xu, Rui-hua]的文章
百度学术
百度学术中相似的文章
[Sun, Guo-ping]的文章
[Sun, Yan]的文章
[Xu, Rui-hua]的文章
必应学术
必应学术中相似的文章
[Sun, Guo-ping]的文章
[Sun, Yan]的文章
[Xu, Rui-hua]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。